You are here

P&T News

October 27

National surveys measure APM implementation in commercial, Medicare Advantage, and Medicaid markets
Researchers reconstruct origins of pandemic
OTL 38 attaches to cancer cell receptors
Neutrophil-to-lymphocyte ratio flops in UPenn study

October 26

First-in-class PARP inhibitor is studied in BRCA-mutated tumors
Auvi-Q device takes advantage of Mylan’s woes
Court records reveal campaign to stop preauthorization efforts
Product’s efficacy and safety profiles are equivalent to those of Humira

October 25

Pexiganan cream is no more effective than placebo
California physician questions “bureaucratic blather”

October 24

Therapeutic protein aids antibacterial drug treatment
Nonlive recombinant vaccine reduces postherpetic neuralgia in phase 3 studies